Background: Human milk (HM) is believed to improve feeding tolerance in very low birth weight (VLBW) infants compared to formula feeding thereby accelerating early enteral feeding advancement. Objective: The present secondary analysis of a controlled randomized trial was to investigated whether human milk accelerates early enteral feeding advancement compared to formula feeding.
NEW AND IMPROVED POPULATION-BASED GERMAN REFERENCE DATA FOR PRE-TERM INFANTS GROWTH
Background: Preterm infants growth is best described in form of standard deviation scores (SD scores or z-scores). Effects of nutritional interventions are assessed easily with z-scores. The z-score of a measurement such as weight indicates how far and in what direction that measurement deviates from its distribution's mean, expressed in units of its standard deviation. However, there are no pertinent German population based reference curves available enabling clinicians to easily convert preterm infants growth status into z-scores. Objective: Aim of the present study was to provide a new growth reference for preterm infants as z-scores.
Methods: Normalized growth standards were constructed by the LMS method (Cole TJ. J Clin Nutr 1990;44(1):45-60) from a cohort of 1.8 million German singleton newborns born from 1995 to 1997. Data were divided into distinct gestational age groups according to completed weeks of gestation. The power (L), mean (M) and coefficient of variation (S) were calculated for each week of gestation for the variables birth weight, length, head circumference, and weight for length. Finally smoothed L, M and S curves were computed by standard mathematical procedures.
Results: From 20 to 43 weeks of gestation the L, M and S values for the assessed variables will be presented together with corresponding smoothed curves. If A is the measured anthropometry for the preterm infant, then the z-score is calculated as: zϭ((A/M) L -1)/(LS). For example for the weight of boys at 25 weeks of postmenstrual age Mϭ790g, Lϭ0.23, and Sϭ0.20. An actual body weight of 500g would correspond to a z-score of -2.2. The full set of data does not fit in this abstract and will be presented at the convention.
Conclusion:
The presented data help to assess the growth of preterm infants. Disclosure: The biometrical evaluation was supported by Milupa, Germany. Methods: In a double-blind placebo controlled trial 128 preterm infants less than 30 weeks of gestation were stratified according to their gestational age (23-26 and 27-29 weeks) and randomly assigned to have their milk feedings (human milk or preterm formula) supplemented with B. lactis (6 x 10 9 cfu/kg/day) or placebo for the first six weeks of life. Early enteral nutrition following a standardized feeding protocol was performed. Primary outcome was the incidence density of nosocomial infections from day 7 after initiation of milk feedings until the 42nd day of life (number of nosocomial infections/total number of patient days). In case of suspected nosocomial infection both aerob and anaerob blood cultures were performed. Nosocomial infections were defined as periods of elevated CRP (C-reactive protein; Ͼ10 mg/dl). The sample size was calculated to proof a reduction in the incidence density of nosocomial infections of at least 25% (áϭ0.05, âϭ0.80). An adaptive interim analysis was scheduled to be performed after at least 50 infants in each group who were treated according to protocol. Data are presented as median and range where appropriate. 
EFFECT OF BIFIDOBACTERIUM LACTIS ON THE INCIDENCE OF NOSOCOMIAL IN-FECTIONS IN PRETERM INFANTS

Results:
The trial was stopped at the interim analysis for futility. There was no significant difference between the two groups with regard to clinical characteristics, patient days, total number of observed nosocomial infections and the incidence density of nosocomial infections (p ϭ 0.9, Chi 2 -test). B. lactis has not been detected in any of the blood cultures.
Conclusion: In the setting of the study treatment with B. lactis at a dosage of 6 x 10 9 cfu/kg/day appeared to be safe, however, there was no reduction in the incidence density of nosocomial infections.
Disclosure: The study was supported by Nestlé, Germany. Background: C reactive protein (CRP) is a major acute-phase plasma protein displaying rapid and pronounced rise of its serum concentration in response to infection or tissue injury. CRP is usually synthesized by hepatocytes and induced by cytokines. However, extrahepatic synthesis has been recently documented. In particular, CRP has been detected in adult human respiratory tract and it has been shown that its gene is expressed in epithelial cells.
C-REACTIVE PROTEIN IN THE TRACHEOBRONCHIAL SECRETION OF A PRETERM INFANT
Methods: Tracheobronchial secretions (TBS) were collected longitudinally in an infant delivered at 24ϩ3 weeks of gestation who developed a middle right lobe pneumonia 5 weeks after delivery. Cultures of TBS were positive for Staphylococcus aureus. Antibiotic therapy with 100 mg/kg/day of amoxicillin/clavulanic acid and 7.5 mg/kg/day of amikacin was administered intravenously for 10 and 5 days, respectively. Nephelometry was used for the determination of CRP in neonatal serum, while a commercially available ELISA test was utilized for the measurement of both blood and TBS CRP concentrations. The sensitivity of the CRP assay was 0.39 ng/mL (Inter-assay coefficient of variation: 6.5%). To provide evidence that CRP is produced locally in the tracheobronchial system a ratio between CRP and IgG both in serum and in the TBS were calculated. The reason for this is twofold: first, IgG and CRP have a similar molecular size, and second, it is known that IgG are present in extremely low concentrations on the mucosal surface. To allow comparison, CRP and IgG concentrations in TBS were normalized to the total protein content.
Results: CRP was present in TBS. A marked increase of CRP in serum and in the TBS was noted during the course of pneumonia with a sharp decrease after antibiotic therapy. The highest CRP concentration in serum (160 mg/L) and TBS (345.9 ng/ml) was found 2 and 3 days after the diagnosis was made, respectively. The CRP -IgG ratio was 21340 times higher in the TBS than in serum. Serum CRP and TBS CRP decrease was observed 1 and 2 days after the initiation of antibiotic therapy, respectively.
Conclusion: CRP is detectable in the TBS of preterm infants during pneumonia. It can be speculated that CRP is not only involved in a systemic response against pathogens but also acts as a mediator in the local defense. It remains to be explored whether TBS CRP measurement is of value in clinical practice.
